Federal Circuit Clarifies Inclusion of New Evidence in IPR Proceedings: Rembrandt Diagnostics v. Alere Case Analysis

In a recent legal development clarified by the US Court of Appeals for the Federal Circuit, a ruling was passed addressing the inclusion of new evidence in petitioner replies during inter partes review (IPR) proceedings. The case in question involved Rembrandt Diagnostics, LP v. Alere, Inc., a dispute with far-reaching implications for how evidence is presented and debated in IPR proceedings.

The court clarified that petitioners are not offering new theories improperly if their arguments merely build upon previously raised points. This conclusion extends to instances when the petitioner responds to the patent owner’s assertions without putting forward an argument that could be deemed by the court as a “meaningfully distinct [invalidity] contention.”

This ruling underscores the extent to which litigators may develop their cases within the legal framework of IPR proceedings. In essence, as long as the new evidence or argument remains rooted in, and responsive to the original contentions and assertions made in the case, it is considered legitimate by the court.

This legal clarification also emphasises on the judicial priority of maintaining an open and fair dialogue between the arguing parties. It enables both petitioners and the patent owners to effectively respond to each other’s legal positions and reduces the likelihood of surprise elements mid-dispute, thereby allowing all the participants to adequately prepare their defense strategies based on the original assertions.

For further case details and legal implications, visit the full case review on JD Supra.